Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2026 08:27 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds

Grand Cayman, May 15, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi)...
May 14, 2026 09:27 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer

Grand Cayman, Cayman Islands, May 14, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA...
May 14, 2026 09:03 ET | Source: Sonablate

Sonablate Launches SONA FUSION Global Registry to Advance Precision Sound Medicine and Define Future Standards in Focal Therapy

Sonablate launched their SONA FUSION Registry, a first-of-its-kind global outcomes initiative designed to unify international real-world evidence for HIFU.
May 14, 2026 08:00 ET | Source: Personalized Medicine Coalition

New PMC Report Shows FDA Advancing a New Era of Personalized, Patient-Centered Care

Washington, DC, May 14, 2026 (GLOBE NEWSWIRE) -- The Personalized Medicine Coalition released a new report documenting the U.S. Food and Drug Administration’s continued progress in advancing...
May 13, 2026 08:00 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center

Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with global leading manufacturing partner Catalent at its...
May 08, 2026 04:03 ET | Source: Research and Markets

Spatial Genomics and Transcriptomics Research Report 2026 - Global Market Analysis, Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031

Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Spatial Genomics and Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F" has been added to ...
May 07, 2026 10:04 ET | Source: Research and Markets

Post-Marketing Pharmacovigilance and Medical Information Market Analysis Report 2026: $11.89 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Post-Marketing Pharmacovigilance and Medical Information Market Report 2026" has been added to ResearchAndMarkets.com's offering. The...
April 30, 2026 12:06 ET | Source: Research and Markets

Biopharmaceutical CMO and CRO Research Report 2026: $48.79 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CMO and CRO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The biopharmaceutical Contract...
April 30, 2026 11:57 ET | Source: Research and Markets

Topical Drugs Contract Development and Manufacturing Organization (CDMO) Market Research Report 2026: $121 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts 2020-2035

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Topical Drugs Contract Development and Manufacturing Organization (CDMO) Market Report 2026" has been added to ResearchAndMarkets.com's offering. ...
April 30, 2026 09:03 ET | Source: Sonablate

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Brad Saar joins Sonablate board to support growth of non-invasive prostate cancer treatment to signal next phase of expansion for HIFU-based prostate care.